Although SPOP is broadly recognized as a tumor suppressor in prostate cancer and SPOP mutations are associated with high frequency of genomic rearrangements, the molecular mechanisms by which SPOP mutations promote genome instability remain poorly understood. The gene discussed is SPOP; the disease is prostate carcinoma.